Avastin's Next Stop May Be Hearing As FDA Starts Withdrawal Process For Breast Cancer Claim
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency officials stress that FDA is eager to work with Genentech on future studies to identify a subpopulation of responders.